John M. Padfield

Lorantis Ltd. used to discover and develop drugs. The company had discovered a fundamental immune mechanism, by which the immune response to any disease-causing antigen may be suppressed. It used pursue immunology drug discovery and development programmes to address unmet medical needs. Lorantis was founded in 1998 and was headquartered in Cambridge, UK

NextPharma Technologies, In. develops, manufactures, packages, and distributes pharmaceutical products and formulations. The firm focuses on lyophilization, sterile fill finish and pellet technologies, and in product manufacturing including cyotoxics, hormones, penicillins, cephalosporins, and controlled drugs. The company was established on October 27, 2000 and is headquartered in London, the United Kingdom.

GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom.

Optos Plc manufactures and markets retinal imaging devices. Its products include ultra-widefield imaging, visual acuity, perimetry, and laser treatment products. The company was founded by Douglas Crombie Anderson in 1992 and is headquartered in Dunfermline, the United Kingdom.

Cambridge Laboratories is a fast growing, dynamic and entrepreneurial pharmaceutical company with extensive product development and commercialization expertise. Their focus is on specialist pharmaceuticals with core products in Oncology and diseases of the central nervous system (CNS). They have a proven track record in the development, global registration, marketing, sales and distribution of both innovative and well established pharmaceutical products. This combined with its strong product portfolio and their ability to forge lasting relationships with global partners, has helped them generate substantial sales growth over the past 13 years. They are proud of its independence and entrepreneurial culture. Equally, their strong balance sheet and freedom from debt give them a solid foundation from which they continue to enhance its growth. Cambridge Laboratories is an independent and privately owned company, founded in 1987 and purchased outright by members of the current Board of Directors in 1996.

NextPharma Technologies Holding Ltd. operates as a pharmaceutical contract development and manufacturing firm. It specializes in modified release technologies and in product manufacturing including hormones, penicillin, and cephalosporin. The company was founded on January 2, 2003 and is headquartered in London, the United Kingdom.